Nym Welcomes Benjamin Gold as Senior Vice President of Product

Nym, the leader in autonomous medical coding, today announced that Benjamin Gold has joined the Company's executive leadership team as Senior Vice President of Product. Gold joins Nym during an exciting period of growth, with the Company recently expanding its autonomous coding solution's capabilities to support new specialty areas such as outpatient surgery and inpatient professional services. In his role as SVP of Product, Gold will lead the Company's product strategy and development, focusing on deploying new coding specialties, scaling Nym's delivery capabilities, and exploring additional opportunities in the payer market.

"I'm delighted to join the Nym team and to be part of a cutting-edge company on the forefront of innovation in healthcare revenue cycle management," said Gold. "Nym's leading autonomous medical coding technology is truly transforming medical coding for healthcare providers, and I can't wait to bring my experience to the team as we develop new product capabilities and deliver even greater value for our customers."

Gold comes to Nym with years of experience creating, delivering, and scaling healthcare technology products, most recently serving as Vice President of Product at Optum. In his role at Optum, Gold managed a $200M+ portfolio of software products across the provider and payer segments with solutions in clinical decision support, prior authorization, provider analytics, inpatient utilization management, utilization review automation, and interoperability product lines, establishing himself as an industry leader in revenue cycle management and informatics. Prior to his role at Optum, Gold spent over five years in various product leadership roles at Change Healthcare (acquired by Optum in 2022), having previously managed product lines at the privately-backed start-up National Decision Support Company (acquired by Change Healthcare in 2018).

"I am thrilled to welcome such an experienced industry leader like Ben to Nym's executive leadership team," said Or Peles, Chief Executive Officer at Nym. "His proven track record of successfully developing, delivering, and scaling healthcare technology products will be integral as Nym expands the capabilities of our autonomous medical coding solution to further reduce the costs and administrative burdens associated with healthcare revenue cycle management."

Powered by innovative Clinical Language Understanding (CLU) technology, Nym's medical coding engine is bringing greater accuracy and efficiency to revenue cycle management for over 250 healthcare facilities across the U.S. The Nym engine deciphers physician notes in patient charts and assigns medical billing codes, currently supporting six specialties and service lines including emergency medicine, radiology, outpatient surgery, outpatient visits, inpatient professional services, and urgent care. With zero human intervention, Nym's engine codes patient charts in a matter of seconds with over 95 percent accuracy, enabling healthcare providers to optimize resource allocation and reduce coding costs, the risk of denials, and missed revenue.

About Nym

Nym is the leader in transforming clinical language into actionable information, which can remove inefficiencies that add billions to the cost of care. By combining industry-leading technology with clinical expertise and a deep understanding of medical language, Nym is able to accurately decode medical charts in a way that is fast, explainable, and compliant. The Company's innovative solution for revenue cycle management (RCM) takes provider notes within patient charts and translates them into accurate diagnostic and billing charge codes, all within a matter of seconds and with zero human intervention. Along with over 95% accuracy, Nym's RCM solution delivers audit-ready, traceable documentation for every code it generates, ensuring total visibility into why each code was assigned. The Nym solution can be quickly deployed and scaled based on volume and workflow needs, easing administrative burdens and allowing clinical teams to spend more time focused on patient care.

Based in New York City with R&D capabilities in Tel Aviv, Nym is building an interdisciplinary team of specialists including technologists, physicians, mathematicians, computational linguists, engineers, medical coders and more. Investors in Nym include Addition, GV, Bessemer Venture Partners, Dynamic Loop Capital, Tiger Global, Zach Weinberg and Nat Turner. To learn more about Nym, visit nym.health.